Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a…
Year: 2020
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with…
BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ:…
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2020 Financial Results
– Received IMPD Approval to Commence Enrollment in France for Pivotal Phase 3 Study of…
Phathom Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
FLORHAM PARK, N.J., Nov. 13, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late…
Adamas Announces New Employment Inducement Grant
EMERYVILLE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced…
Zosano Pharma Reports Third Quarter 2020 Financial Results
FREMONT, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,…
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
LEXINGTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
Cronos Group Inc. to Present at the Jefferies Virtual West Coast Consumer Conference
TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
CENTOGENE Announces Nomination of Jonathan Sheldon to Supervisory Board
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2020 (GLOBE NEWSWIRE) — CENTOGENE (Nasdaq:…
Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)
Updated coverage decision from Novitas Solutions marks major milestone, as Company advances toward full-scale commercialization…
CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza
One-dose, oral Xofluza has been recommended for approval for the treatment of uncomplicated influenza in…
Apellis Announces Late-Breaking Presentation of Largest Retrospective Database Study in Geographic Atrophy (GA) at AAO 2020 Virtual
Verana Health analysis of American Academy of Ophthalmology IRIS® Registry presented in a late-breaking oral…
Braingrid Limited Announces Completion of Share Consolidation
TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”),…
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association’s Virtual Scientific Sessions 2020
VASCEPA®, compared with placebo, significantly reduced primary composite first and total major adverse cardiovascular events…
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced…
AnaptysBio to Present at the 2020 Jefferies London Virtual Healthcare Conference
SAN DIEGO, Nov. 13, 2020 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
Todos Medical CEO Provides Corporate Update
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 13, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical…
Cassava Sciences Announces Pricing of $75 Million Public Offering of Common Stock
AUSTIN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”…
ContraFect Reports Third Quarter 2020 Financial Results and Provides Business Update
CARB-X and Cystic Fibrosis Foundation grants provide significant additional funding to advance CF-370 for Pseudomonas…